跳至主要内容
临床试验/NCT01381432
NCT01381432已完成不适用

Special Drug Use Investigation for IMURAN (Azathioprine) Tablet (Pulmones Transplantation)

GlaxoSmithKline0 个研究点目标入组 39 人开始时间: 2004年12月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
39
主要终点
Incidence of adverse events related to azathioprine tablets

研究概览

简要总结

This post-marketing surveillance study is to investigate the efficacy and safety of azathioprine tablets in subjects whom lung transplantation is performed.

研究设计

研究类型
Observational
时间视角
Prospective

入排标准

性别
All
接受健康志愿者

入选标准

  • Subjects who undergo lung transplantation and azathioprine tablets were administered

排除标准

  • Subjects with hypersensitivity to the ingredients of azathioprine tablet
  • Subjects who is pregnant or might be pregnant
  • Subjects whose white count is lower than 3000/cubic millimeter

研究组 & 干预措施

Subjects prescribed azathioprine tablet

Subjects prescribed azathioprine tablet during study period after the lung transplantation

干预措施: Azathioprine (Drug)

结局指标

主要结局

Incidence of adverse events related to azathioprine tablets

时间窗: 3 years

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

相似试验